We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Trillium Therapeutics Inc | NASDAQ:TRIL | NASDAQ | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 18.44 | 20.33 | 18.30 | 0 | 01:00:00 |
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
___________________
FORM 6-K
REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR
15d-16 OF
THE SECURITIES EXCHANGE ACT OF 1934
For the month of March 2016
Commission File Number: 001-36596
___________________
TRILLIUM THERAPEUTICS INC.
(Translation of registrant's name into English)
96 Skyway Avenue
Toronto, Ontario M9W 4Y9
Canada
(Address of principal executive offices)
___________________
Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.
Form 20-F [ ] Form 40-F [X]
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1)[ ]
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7)[ ]
DOCUMENTS FILED AS PART OF THIS FORM 6-K
See the Exhibit Index hereto.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
Trillium Therapeutics Inc. | |
Date: March 21, 2016 | |
By: /s/ James Parsons | |
Name: James Parsons | |
Title: Chief Financial Officer |
2
EXHIBIT INDEX
Exhibit | Description |
99.1 | Notice of the Meeting and Record Date |
100 University Avenue, 8th floor | |
Date: March 21, 2016 | Toronto ON, M5J 2Y1 |
www.computershare.com |
To: All Canadian Securities Regulatory Authorities
Subject: TRILLIUM THERAPEUTICS INC.
Dear Sir/Madam:
We advise of the following with respect to the upcoming Meeting of Security Holders for the subject Issuer:
Meeting Type : | Annual General and Special Meeting |
Record Date for Notice of Meeting : | April 15, 2016 |
Record Date for Voting (if applicable) : | April 15, 2016 |
Beneficial Ownership Determination Date : | April 15, 2016 |
Meeting Date : | May 27, 2016 |
Meeting Location (if available) : | Mississauga, ON |
Issuer sending proxy related materials directly to NOBO: | No |
Issuer paying for delivery to OBO: | No |
Notice and Access (NAA) Requirements: | |
NAA for Beneficial Holders | Yes |
Beneficial Holders Stratification Criteria: | Not Applicable |
NAA for Registered Holders | Yes |
Registered Holders Stratification Criteria: | Not Applicable |
Voting Security Details:
Description | CUSIP Number | ISIN |
COMMON SHARES | 89620X506 | CA89620X5064 |
Sincerely,
Computershare
Agent for
TRILLIUM THERAPEUTICS INC.
1 Year Trillium Therapeutics Chart |
1 Month Trillium Therapeutics Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions